TY  - JOUR 
AU  - Melguizo Alonso, Consolación
AU  - Prados Salazar, José Carlos
AU  - Alvarez, Pablo Juan
AU  - Perazzoli, Gloria
AU  - Oliver, Jaime Antonio
AU  - López, Rodrigo
AU  - Rodríguez Serrano, Fernando
AU  - Aránega Jiménez, Antonia
PY  - 2012
UR  - http://hdl.handle.net/10481/64171
AB  - Background: The CD133 antigen is a marker of radio- and chemo-resistant stem cell populations in glioblastoma
(GBM). The O6-methylguanine DNA methyltransferase (MGMT) enzyme is related with temozolomide (TMZ)
resistance. Our propose is to analyze...
LA  - eng
PB  - Elsevier SCI LTD
KW  - Glioblastoma
KW  - Radiotherapy
KW  - Temozolomide
KW  - MGMT
KW  - Methylation
KW  - CD133
TI  - MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
DO  - 10.1186/1479-5876-10-250
ER  -